to improve anti-cancer therapy effectiveness and to meaningfully impact the quality of life for patients." In October 2024, Lutris successfully completed enrollment in the international phase 2 trial of LUT014 in patients with metastatic colorectal...
zebrafish embryos. Their study was published in the Journal of Hazardous Materials, made available online on 28 November, 2024. For this, the researchers used a methyl tert-butyl ether (MTBE)-based extraction strategy using a single biological...
$1 million financing between NLS and an accredited investor under a securities purchase agreement dated December 4, 2024, with the approval of certain items in NLS's extraordinary general meeting on January 7, 2025. As previously detailed in NLS's...
disease linking basic research to clinical practice in pursuit of our theme: Exploring New Frontiers in Metabolism. WCIRDC 2024 will return to a live, in-person meeting at the Hilton Universal City Hotel in Los Angeles, on December 12-14, 2024....
B-cell non-Hodgkin lymphoma (B-NHL) including Part 1 (dose escalation) and Part 2 (dose expansion). As of the November 20, 2024 cutoff date, a total of 29 B-NHL patients from Part 1 and Part 2 across all dose levels were treated and evaluated for...
industry trends and client needs, earning her recognition as a trusted advisor to both clients and colleagues. In 2024, Nicole joined Petauri to develop and lead the organization's US HEOR consultancy team. In this role, she is building the...
to its leading molecule, PLT012, for treating liver and intrahepatic bile duct cancer (HCC/ICCA). Achieved in November 2024, this designation marks a crucial advancement in developing innovative therapies for patients facing these challenging...
and additional data at the upcoming Innovation in Obesity Therapeutics Summit in San Diego, CA, on December 11-12, 2024. Biolexis Co-founder Dr. David Bearss will present the latest data on BLX-7006's efficacy and its potential to provide a safe,...
of Best Children’s Hospitals. CHLA is the top-ranked children’s hospital in California and the Pacific U.S. region for 2024-25. Children’s Hospital Los Angeles embraces its mission to create hope and build healthier futures. Children’s Hospital Los...
for regulatory approval of lecanemab in 16 other countries and regions, including the European Union. In November 2024, the treatment received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending approval. A...
with advanced or refractory cancers expressing DLL3. A Phase I clinical trial of PT217 is also ongoing in China (CTR20242720). Earlier this year, Phanes entered into a clinical supply agreement with Roche to study PT217 in combination with Roche's...
"LEQEMBI®" has been launched in South Korea. LEQEMBI received the Ministry of Food and Drug Safety (MFDS) approval in May 2024 for treatment in adult patients with mild cognitive impairment due to Alzheimer's disease (AD) or mild AD dementia (early...
NS Pharma, Inc. announced a change of leadership within its Commercial division. Effective September 9, 2024, Donald Foy – who had previously served as national sales director – was appointed to the role of vice president, Commercial. Jennifer...
is pleased to announce the “International conference on Pharmaceutics and Drug Delivery Systems” to be held on Nov 26-27, 2024 at Dubai, UAE. Genvio Group is pleased to announce the “International conference on Pharmaceutics and Drug Delivery...
often nonfunctional protein and effectively causing a loss of function. Their study appeared online on November 01, 2024 in the journal Experimental & Molecular Medicine. Highlighting the significance of this achievement, senior author Prof. Lee...
International Conference on Neuroscience and Neurology” in Amsterdam, Netherlands, on November 18-20, 2024. International Conference on Neuroscience and Neurology” in Amsterdam, Netherlands, on November 18-20, 2024. This Neurology conference and...
compliant marketing. Axonal.AI was founded by Larry Mickelberg, who was named earlier this year as one of MM+M Magazine’s 2024 Top Healthcare Marketing Influencers. With over 20 years of leadership experience at leading management consultancies and...
Aadi Bioscience, Inc. announced financial results for the third quarter ended September 30, 2024, and provided recent corporate progress. "The third quarter saw strong sales growth for FYARRO, backed by continued account momentum, increased demand...
to discovering and developing innovative medicines for patients, reported financial results for the third quarter of 2024 and provided business updates. HanAll ended the third quarter with total revenue of 36.8 billion KRW, reflecting an 11.7%...
2nd International Conference on Biotechnology and Bioengineering, a Hybrid Event scheduled from October 24-25, 2024, Paris, France. We cordially invite competitors from all corners of the globe to showcase their expertise, talents, and research in...
